Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis
Details
Serval ID
serval:BIB_C2AD6C85751E
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis
Journal
Journal of Rheumatology
ISSN
0315-162X (Print)
Publication state
Published
Issued date
12/1999
Volume
26
Number
12
Pages
2602-8
Notes
Clinical Trial
Clinical Trial, Phase I
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't --- Old month value: Dec
Clinical Trial, Phase I
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't --- Old month value: Dec
Abstract
OBJECTIVE: To determine the safety and immunogenicity of an idiotypic anti-dsDNA vaccine in patients with nonactive systemic lupus erythematosus (SLE) and stable lupus nephritis. METHODS: Patients with SLE with a history of nephritis were randomized for vaccination with the murine anti-dsDNA monoclonal antibody (Mab) 3E10 in a dose ranging, double blind, placebo controlled study (phase I). RESULTS: Of the 9 patients injected with Mab 3E10, 5 showed a human anti-mouse antibody (HAMA) response, in large part antiidiotypic, which developed within the first 3 months in 3 strong HAMA responders, and more than one year after immunization in an initially weak HAMA responder. All but one nonresponder were receiving low dose prednisone. No adverse events, in particular no evidence of lupus flares, and no untoward laboratory findings were reported over a followup of 2 years. CONCLUSION: In patients with stable lupus nephritis, immunization with Mab 3E10 appears safe and can generate a significant antiidiotypic response. Idiotypic vaccination may be an approach to specific immunotherapy of autoimmune lupus nephritis.
Keywords
Adult
Aged
Animals
Antibodies, Antinuclear/blood/immunology
Antibodies, Monoclonal/*administration & dosage
Creatinine/blood
DNA/*immunology
Double-Blind Method
Female
Follow-Up Studies
Hemoglobins
Humans
Immunotherapy
Leukocyte Count
Lupus Erythematosus, Systemic/complications/immunology/*therapy
Lupus Nephritis/etiology/immunology/*therapy
Male
Mice
Middle Aged
Platelet Count
Serum Albumin
Treatment Outcome
*Vaccination
Pubmed
Web of science
Create date
25/01/2008 16:19
Last modification date
20/08/2019 16:37